Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Lars Fruergaard Jorgensen's departure comes a week after the company downgraded its sales and profits forecast, and follows a more than 50% decline in the company's shares since mid-2024.

It’s the end of an era at Novo Nordisk as longtime CEO Lars Fruergaard Jørgensen—who recently shepherded the company through its GLP-1 growth boom—heads for the exit. Under a mutual ...

Lars Fruergaard Jorgensen, who has headed the Danish pharmaceutical company for eight years, will step down after a period to support a smooth transition to new leadership.

Danish drugmaker Novo Nordisk announced Friday that CEO Lars Fruergaard Jørgensen will step down, marking a significant leadership shakeup as the company navigates increasing pressure in the ...

Novo Nordisk has announced that Lars Fruergaard Jørgensen will step down as CEO, following a mutual agreement with the company’s board of directors. According to the company, Jørgensen is expected to ...

The company behind popular new drug Ozempic says its CEO, Lars Fruergaard Jorgensen, will step down following a plunge in the company's share price. Danish pharmaceutical giant Novo Nordisk's ...

You can reach Andrew on Signal at drewqjoseph.45. LONDON — Lars Fruergaard Jørgensen, who led Novo Nordisk as it rode the boom of its obesity and diabetes medications to become one of the ...

All money will go to them": Slaughter To Prevail frontman Alex Terrible has adopted two bear cubs and our hearts might just explode "Lars Ulrich came barging in. He’s like, ‘Hey, I’m Lars!’ F*** yeah ...

Lars Fruergaard Jorgensen is being forced out after the Danish firm's board came under pressure from the foundation that controls the company. The shake-up follows Novo's leading position in the ...